Pt Kalbe Farma TbkIDX: KLBF

Company Update - Q1 2025 Unaudited Results (09-May-2025)

· Issued by PT Kalbe Farma Tbk

Company Update 1Q25

PT Kalbe Farma Tbk

May 2025



Table of Content

  • Key Updates 04

  • Business Strategies 08

  • Financial Overview 23

  • Appendix 1 30

  • Appendix 2 37



Key Updates



Market Capitalization More than Half a Century of Providing Wide-Range Healthcare Solutions

Corporate Overview

Prescription

Pharmaceuticals

Indonesian integrated healthcare company with regional footprint

1966

Established, headquartered in Jakarta

1991

Listed in the

Indonesia Stock Exchange

Onwards

The

most

integrated

healthcare company in

Southeast Asia

6%

Export

Middle

East

SEA

±40

Countries

South

Africa



IDR 53.2 tn ($3.2 bn)* free float

*

42.01%

Including treasury stocks

32.5%

28.1%

Net Sales

IDR 8,845 bn

1Q 2025

(unaudited)

15.4%

24.0%

Consumer Health

Nutritionals

Distribution & Logistics

* As of 31 Mar 25



Attention: This is an excerpt of the original content. To continue reading it, access the original document here.